Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment

This study tracked five pharmaceutically active compounds (PhACs) in Mexico City's sewage, namely, famotidine, indomethacin, dexamethasone, azithromycin, and ivermectin, which were used to treat COVID-19. The monitoring campaign was carried out over 30 months (May 2020 to November 2022), coveri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Science of the total environment 2023-11, Vol.900, p.165886-165886, Article 165886
Hauptverfasser: Durán-Álvarez, Juan C., Prado, Blanca, Zanella, Rodolfo, Rodríguez, Mario, Díaz, Suhaila
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 165886
container_issue
container_start_page 165886
container_title The Science of the total environment
container_volume 900
creator Durán-Álvarez, Juan C.
Prado, Blanca
Zanella, Rodolfo
Rodríguez, Mario
Díaz, Suhaila
description This study tracked five pharmaceutically active compounds (PhACs) in Mexico City's sewage, namely, famotidine, indomethacin, dexamethasone, azithromycin, and ivermectin, which were used to treat COVID-19. The monitoring campaign was carried out over 30 months (May 2020 to November 2022), covering the five COVID-19 waves in Mexico. In the Central Emitter, the main sewage outflow, famotidine displayed levels of 132.57 ± 28.16 ng L−1 (range from < LOQ to 189.1 ng L−1), followed by indomethacin (average 672.46 ± 116.4 ng L−1, range from 516.7 to 945.2 ng L−1), dexamethasone (average 610.4 ± 225.7 ng L−1, range from 233.4 to 1044.5 ng L−1), azithromycin (average 4436.2 ± 903.6 ng L−1, range from 2873.7 to 5819.6 ng L−1), and ivermectin (average 3413.3 ± 1244.6 ng L−1, range from 1219.8 to 4622.4 ng L−1). The concentrations of dexamethasone, azithromycin and ivermectin were higher in sewage from a temporary COVID-19 care unit, by a factor of 3.48, 3.52 and 2.55, respectively, compared with those found in municipal wastewater. In the effluent of the Atotonilco Wastewater Treatment Plant (AWWTP), which treats near 60 % of the Mexico City's sewage, famotidine was absent, while concentrations of indomethacin, dexamethasone, azithromycin and ivermectin were 78.2 %, 76.7 %, 74.4 %, and 88.1 % lower than those in the influent, respectively. The occurrence of PhACs in treated and untreated wastewater resulted in medium to high environmental risk since Mexico City's wastewater is reused for irrigation in the Mezquital Valley. There, PhACs were found in irrigation canals at lower levels than those observed in Mexico City throughout the monitoring. On the other hand, famotidine, indomethacin, and dexamethasone were not found in surface water resulting from the infiltration of wastewater through soil in Mezquital Valley, while azithromycin and ivermectin sporadically appeared in surface water samples collected through 2021. Using an optimized risk assessment based on a semi-probabilistic approach, the PhACs were prioritized as ivermectin > azithromycin > dexamethasone > famotidine > indomethacin. [Display omitted] •COVID-19 drugs tracked in Mexico City's sewage throughout the pandemic.•High levels of dexamethasone, azithromycin and ivermectin found through the survey.•Azithromycin and ivermectin levels in sewage fit with COVID-19 five waves in Mexico City.•Mexico City exported COVID-19 drugs to Mezquital Valley through sewage during the pandemic.•Ivermectin, dexamethasone a
doi_str_mv 10.1016/j.scitotenv.2023.165886
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2844680384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0048969723045114</els_id><sourcerecordid>2844680384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-69cca5514c0d7e10aa6cc265ce42750d052cae44eaf1f26037d694b26d9db6df3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EokvhFcBHLllsx7ETbquFQqVWvbTlaHntCesliVPbWdg-DM-K0217xRdLo2_m18yH0AdKlpRQ8Wm3jMYln2DYLxlh5ZKKqq7FC7SgtWwKSph4iRaE8LpoRCNP0JsYdyQ_WdPX6KSUFeO0oQv094eOCX7rBAHHKezBdZ0eDGDf4nGrQ68NTMkZ3UVsp-CGnzhtAa-vbs-_FLTBox4s9M5gN-BL-OOMx2uXDjiXH8BLuL-bXNIdvtVdB4fPeIWN78cAWxii2wPOK7jghx6GmQou_sI6RohxrrxFr9ocDe8e_1N0c_b1ev29uLj6dr5eXRSmlDQVojFGVxXlhlgJlGgtjGGiMsCZrIglFTMaOAfd0pYJUkorGr5hwjZ2I2xbnqKPx7lj8HcTxKR6Fw3MtwA_RcVqzkVNyppnVB5RE3yMAVo1BtfrcFCUqFmO2qlnOWqWo45ycuf7x5Bp04N97nuykYHVEYC86t5BmAdBtmFdAJOU9e6_If8AIZqouQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844680384</pqid></control><display><type>article</type><title>Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment</title><source>Access via ScienceDirect (Elsevier)</source><creator>Durán-Álvarez, Juan C. ; Prado, Blanca ; Zanella, Rodolfo ; Rodríguez, Mario ; Díaz, Suhaila</creator><creatorcontrib>Durán-Álvarez, Juan C. ; Prado, Blanca ; Zanella, Rodolfo ; Rodríguez, Mario ; Díaz, Suhaila</creatorcontrib><description>This study tracked five pharmaceutically active compounds (PhACs) in Mexico City's sewage, namely, famotidine, indomethacin, dexamethasone, azithromycin, and ivermectin, which were used to treat COVID-19. The monitoring campaign was carried out over 30 months (May 2020 to November 2022), covering the five COVID-19 waves in Mexico. In the Central Emitter, the main sewage outflow, famotidine displayed levels of 132.57 ± 28.16 ng L−1 (range from &lt; LOQ to 189.1 ng L−1), followed by indomethacin (average 672.46 ± 116.4 ng L−1, range from 516.7 to 945.2 ng L−1), dexamethasone (average 610.4 ± 225.7 ng L−1, range from 233.4 to 1044.5 ng L−1), azithromycin (average 4436.2 ± 903.6 ng L−1, range from 2873.7 to 5819.6 ng L−1), and ivermectin (average 3413.3 ± 1244.6 ng L−1, range from 1219.8 to 4622.4 ng L−1). The concentrations of dexamethasone, azithromycin and ivermectin were higher in sewage from a temporary COVID-19 care unit, by a factor of 3.48, 3.52 and 2.55, respectively, compared with those found in municipal wastewater. In the effluent of the Atotonilco Wastewater Treatment Plant (AWWTP), which treats near 60 % of the Mexico City's sewage, famotidine was absent, while concentrations of indomethacin, dexamethasone, azithromycin and ivermectin were 78.2 %, 76.7 %, 74.4 %, and 88.1 % lower than those in the influent, respectively. The occurrence of PhACs in treated and untreated wastewater resulted in medium to high environmental risk since Mexico City's wastewater is reused for irrigation in the Mezquital Valley. There, PhACs were found in irrigation canals at lower levels than those observed in Mexico City throughout the monitoring. On the other hand, famotidine, indomethacin, and dexamethasone were not found in surface water resulting from the infiltration of wastewater through soil in Mezquital Valley, while azithromycin and ivermectin sporadically appeared in surface water samples collected through 2021. Using an optimized risk assessment based on a semi-probabilistic approach, the PhACs were prioritized as ivermectin &gt; azithromycin &gt; dexamethasone &gt; famotidine &gt; indomethacin. [Display omitted] •COVID-19 drugs tracked in Mexico City's sewage throughout the pandemic.•High levels of dexamethasone, azithromycin and ivermectin found through the survey.•Azithromycin and ivermectin levels in sewage fit with COVID-19 five waves in Mexico City.•Mexico City exported COVID-19 drugs to Mezquital Valley through sewage during the pandemic.•Ivermectin, dexamethasone and azithromycin were priority pollutants based on risk assessment.</description><identifier>ISSN: 0048-9697</identifier><identifier>EISSN: 1879-1026</identifier><identifier>DOI: 10.1016/j.scitotenv.2023.165886</identifier><identifier>PMID: 37524191</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Analgesics ; Antimicrobials ; Environmental risk assessment ; HPLC-MS/MS ; Municipal sewage ; Wastewater reuse</subject><ispartof>The Science of the total environment, 2023-11, Vol.900, p.165886-165886, Article 165886</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-69cca5514c0d7e10aa6cc265ce42750d052cae44eaf1f26037d694b26d9db6df3</citedby><cites>FETCH-LOGICAL-c371t-69cca5514c0d7e10aa6cc265ce42750d052cae44eaf1f26037d694b26d9db6df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.scitotenv.2023.165886$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37524191$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Durán-Álvarez, Juan C.</creatorcontrib><creatorcontrib>Prado, Blanca</creatorcontrib><creatorcontrib>Zanella, Rodolfo</creatorcontrib><creatorcontrib>Rodríguez, Mario</creatorcontrib><creatorcontrib>Díaz, Suhaila</creatorcontrib><title>Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment</title><title>The Science of the total environment</title><addtitle>Sci Total Environ</addtitle><description>This study tracked five pharmaceutically active compounds (PhACs) in Mexico City's sewage, namely, famotidine, indomethacin, dexamethasone, azithromycin, and ivermectin, which were used to treat COVID-19. The monitoring campaign was carried out over 30 months (May 2020 to November 2022), covering the five COVID-19 waves in Mexico. In the Central Emitter, the main sewage outflow, famotidine displayed levels of 132.57 ± 28.16 ng L−1 (range from &lt; LOQ to 189.1 ng L−1), followed by indomethacin (average 672.46 ± 116.4 ng L−1, range from 516.7 to 945.2 ng L−1), dexamethasone (average 610.4 ± 225.7 ng L−1, range from 233.4 to 1044.5 ng L−1), azithromycin (average 4436.2 ± 903.6 ng L−1, range from 2873.7 to 5819.6 ng L−1), and ivermectin (average 3413.3 ± 1244.6 ng L−1, range from 1219.8 to 4622.4 ng L−1). The concentrations of dexamethasone, azithromycin and ivermectin were higher in sewage from a temporary COVID-19 care unit, by a factor of 3.48, 3.52 and 2.55, respectively, compared with those found in municipal wastewater. In the effluent of the Atotonilco Wastewater Treatment Plant (AWWTP), which treats near 60 % of the Mexico City's sewage, famotidine was absent, while concentrations of indomethacin, dexamethasone, azithromycin and ivermectin were 78.2 %, 76.7 %, 74.4 %, and 88.1 % lower than those in the influent, respectively. The occurrence of PhACs in treated and untreated wastewater resulted in medium to high environmental risk since Mexico City's wastewater is reused for irrigation in the Mezquital Valley. There, PhACs were found in irrigation canals at lower levels than those observed in Mexico City throughout the monitoring. On the other hand, famotidine, indomethacin, and dexamethasone were not found in surface water resulting from the infiltration of wastewater through soil in Mezquital Valley, while azithromycin and ivermectin sporadically appeared in surface water samples collected through 2021. Using an optimized risk assessment based on a semi-probabilistic approach, the PhACs were prioritized as ivermectin &gt; azithromycin &gt; dexamethasone &gt; famotidine &gt; indomethacin. [Display omitted] •COVID-19 drugs tracked in Mexico City's sewage throughout the pandemic.•High levels of dexamethasone, azithromycin and ivermectin found through the survey.•Azithromycin and ivermectin levels in sewage fit with COVID-19 five waves in Mexico City.•Mexico City exported COVID-19 drugs to Mezquital Valley through sewage during the pandemic.•Ivermectin, dexamethasone and azithromycin were priority pollutants based on risk assessment.</description><subject>Analgesics</subject><subject>Antimicrobials</subject><subject>Environmental risk assessment</subject><subject>HPLC-MS/MS</subject><subject>Municipal sewage</subject><subject>Wastewater reuse</subject><issn>0048-9697</issn><issn>1879-1026</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkcFu1DAQhi0EokvhFcBHLllsx7ETbquFQqVWvbTlaHntCesliVPbWdg-DM-K0217xRdLo2_m18yH0AdKlpRQ8Wm3jMYln2DYLxlh5ZKKqq7FC7SgtWwKSph4iRaE8LpoRCNP0JsYdyQ_WdPX6KSUFeO0oQv094eOCX7rBAHHKezBdZ0eDGDf4nGrQ68NTMkZ3UVsp-CGnzhtAa-vbs-_FLTBox4s9M5gN-BL-OOMx2uXDjiXH8BLuL-bXNIdvtVdB4fPeIWN78cAWxii2wPOK7jghx6GmQou_sI6RohxrrxFr9ocDe8e_1N0c_b1ev29uLj6dr5eXRSmlDQVojFGVxXlhlgJlGgtjGGiMsCZrIglFTMaOAfd0pYJUkorGr5hwjZ2I2xbnqKPx7lj8HcTxKR6Fw3MtwA_RcVqzkVNyppnVB5RE3yMAVo1BtfrcFCUqFmO2qlnOWqWo45ycuf7x5Bp04N97nuykYHVEYC86t5BmAdBtmFdAJOU9e6_If8AIZqouQ</recordid><startdate>20231120</startdate><enddate>20231120</enddate><creator>Durán-Álvarez, Juan C.</creator><creator>Prado, Blanca</creator><creator>Zanella, Rodolfo</creator><creator>Rodríguez, Mario</creator><creator>Díaz, Suhaila</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231120</creationdate><title>Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment</title><author>Durán-Álvarez, Juan C. ; Prado, Blanca ; Zanella, Rodolfo ; Rodríguez, Mario ; Díaz, Suhaila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-69cca5514c0d7e10aa6cc265ce42750d052cae44eaf1f26037d694b26d9db6df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analgesics</topic><topic>Antimicrobials</topic><topic>Environmental risk assessment</topic><topic>HPLC-MS/MS</topic><topic>Municipal sewage</topic><topic>Wastewater reuse</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Durán-Álvarez, Juan C.</creatorcontrib><creatorcontrib>Prado, Blanca</creatorcontrib><creatorcontrib>Zanella, Rodolfo</creatorcontrib><creatorcontrib>Rodríguez, Mario</creatorcontrib><creatorcontrib>Díaz, Suhaila</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Science of the total environment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Durán-Álvarez, Juan C.</au><au>Prado, Blanca</au><au>Zanella, Rodolfo</au><au>Rodríguez, Mario</au><au>Díaz, Suhaila</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment</atitle><jtitle>The Science of the total environment</jtitle><addtitle>Sci Total Environ</addtitle><date>2023-11-20</date><risdate>2023</risdate><volume>900</volume><spage>165886</spage><epage>165886</epage><pages>165886-165886</pages><artnum>165886</artnum><issn>0048-9697</issn><eissn>1879-1026</eissn><abstract>This study tracked five pharmaceutically active compounds (PhACs) in Mexico City's sewage, namely, famotidine, indomethacin, dexamethasone, azithromycin, and ivermectin, which were used to treat COVID-19. The monitoring campaign was carried out over 30 months (May 2020 to November 2022), covering the five COVID-19 waves in Mexico. In the Central Emitter, the main sewage outflow, famotidine displayed levels of 132.57 ± 28.16 ng L−1 (range from &lt; LOQ to 189.1 ng L−1), followed by indomethacin (average 672.46 ± 116.4 ng L−1, range from 516.7 to 945.2 ng L−1), dexamethasone (average 610.4 ± 225.7 ng L−1, range from 233.4 to 1044.5 ng L−1), azithromycin (average 4436.2 ± 903.6 ng L−1, range from 2873.7 to 5819.6 ng L−1), and ivermectin (average 3413.3 ± 1244.6 ng L−1, range from 1219.8 to 4622.4 ng L−1). The concentrations of dexamethasone, azithromycin and ivermectin were higher in sewage from a temporary COVID-19 care unit, by a factor of 3.48, 3.52 and 2.55, respectively, compared with those found in municipal wastewater. In the effluent of the Atotonilco Wastewater Treatment Plant (AWWTP), which treats near 60 % of the Mexico City's sewage, famotidine was absent, while concentrations of indomethacin, dexamethasone, azithromycin and ivermectin were 78.2 %, 76.7 %, 74.4 %, and 88.1 % lower than those in the influent, respectively. The occurrence of PhACs in treated and untreated wastewater resulted in medium to high environmental risk since Mexico City's wastewater is reused for irrigation in the Mezquital Valley. There, PhACs were found in irrigation canals at lower levels than those observed in Mexico City throughout the monitoring. On the other hand, famotidine, indomethacin, and dexamethasone were not found in surface water resulting from the infiltration of wastewater through soil in Mezquital Valley, while azithromycin and ivermectin sporadically appeared in surface water samples collected through 2021. Using an optimized risk assessment based on a semi-probabilistic approach, the PhACs were prioritized as ivermectin &gt; azithromycin &gt; dexamethasone &gt; famotidine &gt; indomethacin. [Display omitted] •COVID-19 drugs tracked in Mexico City's sewage throughout the pandemic.•High levels of dexamethasone, azithromycin and ivermectin found through the survey.•Azithromycin and ivermectin levels in sewage fit with COVID-19 five waves in Mexico City.•Mexico City exported COVID-19 drugs to Mezquital Valley through sewage during the pandemic.•Ivermectin, dexamethasone and azithromycin were priority pollutants based on risk assessment.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37524191</pmid><doi>10.1016/j.scitotenv.2023.165886</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0048-9697
ispartof The Science of the total environment, 2023-11, Vol.900, p.165886-165886, Article 165886
issn 0048-9697
1879-1026
language eng
recordid cdi_proquest_miscellaneous_2844680384
source Access via ScienceDirect (Elsevier)
subjects Analgesics
Antimicrobials
Environmental risk assessment
HPLC-MS/MS
Municipal sewage
Wastewater reuse
title Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T09%3A43%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wastewater%20surveillance%20of%20pharmaceuticals%20during%20the%20COVID-19%20pandemic%20in%20Mexico%20City%20and%20the%20Mezquital%20Valley:%20A%20comprehensive%20environmental%20risk%20assessment&rft.jtitle=The%20Science%20of%20the%20total%20environment&rft.au=Dur%C3%A1n-%C3%81lvarez,%20Juan%20C.&rft.date=2023-11-20&rft.volume=900&rft.spage=165886&rft.epage=165886&rft.pages=165886-165886&rft.artnum=165886&rft.issn=0048-9697&rft.eissn=1879-1026&rft_id=info:doi/10.1016/j.scitotenv.2023.165886&rft_dat=%3Cproquest_cross%3E2844680384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2844680384&rft_id=info:pmid/37524191&rft_els_id=S0048969723045114&rfr_iscdi=true